A 70-Gene Signature for Predicting Treatment Outcome in Advanced-Stage Cervical Cancer

Cervical cancer is the fourth most common cancer in women worldwide. The current approaches still have limitations in predicting the therapy outcome of each individual because of cancer heterogeneity. The goal of this study was to establish a gene expression signature that could help when choosing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Ngoc Ngo Yen, Choi, Tae Gyu, Kim, Jieun, Jung, Min Hyung, Ko, Seok Hoon, Shin, Yoonhwa, Kang, Insug, Ha, Joohun, Kim, Sung Soo, Jo, Yong Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530249/
https://www.ncbi.nlm.nih.gov/pubmed/33024818
http://dx.doi.org/10.1016/j.omto.2020.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530249/
https://www.ncbi.nlm.nih.gov/pubmed/33024818
http://dx.doi.org/10.1016/j.omto.2020.09.001

Ejemplares similares